SEC Form 4 · accession 0000921895-18-000703
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur M Langer
Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 15, 2018 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 14, 2018 | J | 7,381 | — | A | 84,923 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares granted to the Reporting Person by the Issuer pursuant to the Issuer's 2015 Equity Incentive Award Plan in connection with the resolution of 2017 directors' fee payments owed by the Issuer to the Reporting Person.